Evercore ISI Group Raises argenx (ARGX) Price Target to $1,090
Key Points
- Evercore ISI Group maintained an Outperform rating on argenx SE on October 23, 2026, lifting its price target to $1090.00 from $1078.00.
- Evercore ISI Group's $1,090 price target implies 24.46% upside from argenx SE's ($ARGX) current $875.76 share price.
- The stock recently traded around $875.76 on October 23, 2026, after closing at $869.07 on the same day.
- argenx SE reported trailing twelve-month revenue of $5.32 billion alongside an EPS of $28.87.
Get argenx SE text alerts
We text you when insiders, Congress, analysts or big funds move on $ARGX.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated argenx SE alert may contain errors. Disclosures
On October 23, 2026, Evercore ISI Group maintained its Outperform rating on argenx SE (NASDAQ: ARGX) while lifting its price target from $1078.00 to $1090.00. According to the firm's research note, the updated target points to a higher expected value for the biotechnology developer.
ARGX
argenx SE
Evercore ISI Group vs. the S&P 500
Hypothetical returns from Evercore ISI Group's disclosed trades, not real profit or advice. How we model this.
Evercore ISI Group's Call on argenx SE
Evercore ISI Group issued its view in a note on October 23, 2026, keeping an Outperform rating on the shares and nudging the target up to $1090.00 from $1078.00.
Other Institutional Activity in argenx SE
Jupiter Topco LLC grew its holdings by 1237008 shares, ending with 2474015.0 shares worth about $2,150,092,234.0. Artisan Partners Limited Partnership grew its holdings by 40810 shares, ending with 1508778.0 shares worth about $1,311,233,707.0, marking a 2.8% increase. Avoro Capital Advisors LLC held steady with 1000000.0 shares valued at about $869,070,007.0. RTW Investments LP maintained its stake at 709446.0 shares worth roughly $616,558,240.0.
argenx SE Stock Down 1.6%
Shares of argenx SE recently traded around $875.76 as of October 23, 2026, up about 0.8% from their event-day close of $869.07 on October 23, 2026. The stock sits below its 50-day moving average of $952.65 but stands above its 200-day moving average of $852.26.
$ARGX price target
argenx SE daily closes and this analyst's $1,090 target. Not advice.
Recent Earnings
The company posted trailing twelve-month revenue of $5,315,468,800.0 and basic earnings per share of $28.87. Profitability metrics show a net margin of 32.3% and a return on equity of 23.6%.
Analysts Set New Price Targets
On October 14, 2026, Wells Fargo maintained an Overweight rating and a $1356.0 target, up from $1355.0. RBC Capital maintained an Outperform rating on October 20, 2026, moving its target from $1100.0 to $1025.0. On October 23, 2026, Wells Fargo maintained an Overweight rating while lowering its target from $1356.0 to $1336.0. Baird maintained a Neutral rating on October 23, 2026, raising its target to $861.0 from $823.0. Overall, the stock holds a buy consensus recommendation.
About argenx SE
Based in Amsterdam, Netherlands, argenx SE is a commercial-stage biopharmaceutical company focused on developing treatments for autoimmune diseases. Its portfolio includes therapies like VYVGART and VYVGART HYTRULO for conditions such as generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy.
Bottom Line
Evercore ISI Group's target adjustment offers fresh perspective on the firm's outlook for argenx SE. Investors continue to monitor upcoming research notes and consensus revisions.
Related Filing Alerts
Source: Evercore ISI Group's rating change on $ARGX (Oct 23, 2026). Written by software, not financial advice. How we make alerts